Buchumschlag

Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy

The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However, CFTR modulator therapy is still a life-long treatment, which is not able to correct the genetic defect and cure the disease. Therefore, it becomes crucial to understand the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yi, Buqing (VerfasserIn) , Dalpke, Alexander (VerfasserIn) , Boutin, Sébastien (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 March 2021
In: Frontiers in Cellular and Infection Microbiology
Year: 2021, Jahrgang: 11, Pages: 1-7
ISSN:2235-2988
DOI:10.3389/fcimb.2021.548613
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fcimb.2021.548613
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fcimb.2021.548613/full
Volltext
Verfasserangaben:Buqing Yi, Alexander H. Dalpke and Sébastien Boutin

MARC

LEADER 00000caa a2200000 c 4500
001 1758989661
003 DE-627
005 20220819214847.0
007 cr uuu---uuuuu
008 210526s2021 xx |||||o 00| ||eng c
024 7 |a 10.3389/fcimb.2021.548613  |2 doi 
035 |a (DE-627)1758989661 
035 |a (DE-599)KXP1758989661 
035 |a (OCoLC)1341414576 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Yi, Buqing  |d 1977-  |e VerfasserIn  |0 (DE-588)139815015  |0 (DE-627)613785274  |0 (DE-576)312537794  |4 aut 
245 1 0 |a Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy  |c Buqing Yi, Alexander H. Dalpke and Sébastien Boutin 
264 1 |c 17 March 2021 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.05.2021 
520 |a The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However, CFTR modulator therapy is still a life-long treatment, which is not able to correct the genetic defect and cure the disease. Therefore, it becomes crucial to understand the effects of such modulation of CFTR function on the airway physiology, especially on airway infections and inflammation that are currently the major life-limiting factors in people with cystic fibrosis. In this context, understanding the dynamics of airway microbiome changes in response to modulator therapy plays an essential role in developing strategies for managing airway infections. Whether and how the newly available therapies affect the airway microbiome is still at the beginning of being deciphered. We present here a brief review summarizing the latest information about microbiome alterations in light of modern cystic fibrosis modulator therapy. 
650 4 |a Airway microbiome 
650 4 |a CFTR modulator therapy 
650 4 |a cystic fibrosis 
650 4 |a Host - bacteria interaction 
650 4 |a Pseudomonas aeruginosa 
700 1 |a Dalpke, Alexander  |d 1971-  |e VerfasserIn  |0 (DE-588)123821878  |0 (DE-627)706438523  |0 (DE-576)293894272  |4 aut 
700 1 |a Boutin, Sébastien  |e VerfasserIn  |0 (DE-588)112876217X  |0 (DE-627)883204479  |0 (DE-576)486061353  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in Cellular and Infection Microbiology  |d Lausanne : Frontiers Media, 2010  |g 11(2021), Artikel-ID 548613, Seite 1-7  |h Online-Ressource  |w (DE-627)664968554  |w (DE-600)2619676-1  |w (DE-576)347917410  |x 2235-2988  |7 nnas  |a Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy 
773 1 8 |g volume:11  |g year:2021  |g elocationid:548613  |g pages:1-7  |g extent:7  |a Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy 
856 4 0 |u https://doi.org/10.3389/fcimb.2021.548613  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fcimb.2021.548613/full  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210526 
993 |a Article 
994 |a 2021 
998 |g 112876217X  |a Boutin, Sébastien  |m 112876217X:Boutin, Sébastien  |d 910000  |d 911700  |e 910000PB112876217X  |e 911700PB112876217X  |k 0/910000/  |k 1/910000/911700/  |p 3  |y j 
999 |a KXP-PPN1758989661  |e 3931332683 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy","title":"Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapy"}],"recId":"1758989661","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["Buqing Yi, Alexander H. Dalpke and Sébastien Boutin"]},"person":[{"given":"Buqing","role":"aut","display":"Yi, Buqing","roleDisplay":"VerfasserIn","family":"Yi"},{"roleDisplay":"VerfasserIn","family":"Dalpke","display":"Dalpke, Alexander","role":"aut","given":"Alexander"},{"roleDisplay":"VerfasserIn","family":"Boutin","given":"Sébastien","role":"aut","display":"Boutin, Sébastien"}],"note":["Gesehen am 26.05.2021"],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1758989661"],"doi":["10.3389/fcimb.2021.548613"]},"relHost":[{"id":{"eki":["664968554"],"issn":["2235-2988"],"zdb":["2619676-1"]},"origin":[{"publisherPlace":"Lausanne","publisher":"Frontiers Media","dateIssuedKey":"2010","dateIssuedDisp":"2010-"}],"note":["Gesehen am 21.07.11"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["2010 -"],"part":{"extent":"7","year":"2021","volume":"11","text":"11(2021), Artikel-ID 548613, Seite 1-7","pages":"1-7"},"title":[{"title":"Frontiers in Cellular and Infection Microbiology","title_sort":"Frontiers in Cellular and Infection Microbiology"}],"disp":"Changes in the cystic fibrosis airway microbiome in response to CFTR modulator therapyFrontiers in Cellular and Infection Microbiology","recId":"664968554"}],"origin":[{"dateIssuedDisp":"17 March 2021","dateIssuedKey":"2021"}]} 
SRT |a YIBUQINGDACHANGESINT1720 

Ähnliche Einträge